Chronic Kidney Disease and Diabetes
Chronic Kidney Disease and Diabetes is a research topic within Nephrology. Science Explorer counts 37k research works in it since 1950. 21.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on chronic kidney disease (CKD) and its various aspects including estimation of glomerular filtration rate, association with cardiovascular disease, diabetic nephropathy, renal insufficiency, albuminuria, fibrosis, TGF-ß signaling, and the global burden of CKD. It covers topics related to diagnosis, management, risk factors, and implications of CKD on mortality and cardiovascular outcomes.
- Chronic Kidney Disease
- Glomerular Filtration Rate
- Cardiovascular Disease
- Diabetic Nephropathy
- Renal Insufficiency
- Albuminuria
- Fibrosis
- TGF-ß
- Obesity-related Glomerulopathy
- Global Burden
- Research works
- 37k fractional, since 1950
- In the world top 10%
- 7.7k per year above
- Top-10% rate
- 21.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +25% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Chronic Kidney Disease and Diabetes research?
By volume, China and the United States publish the most (2.4k and 1.4k works in 2022–2025).
By volume, 2022–2025
- 1 China 2.4k works
- 2 United States 1.4k works
- 3 Japan 423 works
- 4 India 374 works
- 5 United Kingdom 297 works
- 6 South Korea 260 works
- 7 Germany 211 works
- 8 Italy 186 works
- 9 Spain 168 works
- 10 Australia 165 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Chronic Kidney Disease and Diabetes research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Chronic Kidney Disease and Diabetes research, followed by Sichuan University and Peking University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 42 works
- 2 Sichuan UniversityChina 33 works
- 3 Peking UniversityChina 32 works
- 4 Sun Yat-sen UniversityChina 31 works
- 5 Capital Medical UniversityChina 30 works
- 6 Nanjing Medical UniversityChina 29 works
- 7 Central South UniversityChina 27 works
- 8 Southern Medical UniversityChina 27 works
- 9 Johns Hopkins UniversityUnited States 25 works
- 10 West China Hospital of Sichuan UniversityChina 25 works
Who are the leading researchers in Chronic Kidney Disease and Diabetes?
The most-cited researchers publishing on Chronic Kidney Disease and Diabetes include Giuseppe Remuzzi, Johan Ärnlöv and Juan Jesús Carrero.
- 1 Giuseppe Remuzzi Italy 8.1k citations
- 2 Johan Ärnlöv Sweden 6.6k citations
- 3 Juan Jesús Carrero Sweden 6.5k citations
- 4 Norberto Perico Italy 6.1k citations
- 5 Marcello Tonelli Canada 5.9k citations
- 6 Alberto Ortíz Spain 5.9k citations
- 7 Hermann Brenner Germany 5.8k citations
- 8 Vivekanand Jha India 5.8k citations
- 9 Josef Coresh United States 5.3k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Chronic Kidney Disease and Diabetes research done?
The largest centres of Chronic Kidney Disease and Diabetes research in 2022–2025 are Beijing (China), Guangzhou (China), Shanghai (China) and Seoul (South Korea).
Where is the best place to study Chronic Kidney Disease and Diabetes?
Among universities, judged by research, Guangzhou University of Chinese Medicine, Nanjing University of Chinese Medicine and Southern Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Guangzhou University of Chinese MedicineChina | 74.0 | 36.3% | 14.7× | 22 | +424.9% |
| 2 | Nanjing University of Chinese MedicineChina | 64.7 | 31.6% | 11.0× | 22 | +98.6% |
| 3 | Southern Medical UniversityChina | 63.9 | 34.8% | 9.5× | 27 | +15.0% |
| 4 | Zhejiang Chinese Medical UniversityChina | 62.6 | 33.1% | 9.9× | 20 | +69.1% |
| 5 | Beijing University of Chinese MedicineChina | 59.7 | 38.0% | 13.9× | 19 | -24.1% |
| 6 | Chongqing Medical UniversityChina | 59.7 | 37.0% | 6.8× | 18 | +138.3% |
| 7 | Chengdu University of Traditional Chinese MedicineChina | 59.3 | 41.6% | 8.8× | 16 | +35.8% |
| 8 | Shanghai University of Traditional Chinese MedicineChina | 58.5 | 31.7% | 13.2× | 20 | +5.7% |
| 9 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 57.7 | 33.6% | 5.4× | 42 | +18.1% |
| 10 | Tianjin Medical UniversityChina | 56.7 | 37.8% | 9.0× | 14 | +20.7% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Chronic Kidney Disease and Diabetes research growing?
Output in 2018–2022 was 25% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Chronic Kidney Disease and Diabetes.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.